Azithromycin in pediatrics patients , for what we can give them
Reading File
Finding Sources
Finding Sources
The Harriet Lane Handbook and Red Book are the gold-standard pediatric references. Let me read those sections now in parallel.
Reading File
Reading File
The Harriet Lane section is very rich. Let me read more of it to get the complete dosing and indications.
Reading File
Reading File
I now have comprehensive data from the Harriet Lane Handbook. Here is the full summary:
Azithromycin in Pediatric Patients
Azithromycin (Zithromax) is a macrolide antibiotic with a broad range of pediatric indications. Below is a structured overview of uses and dosing, sourced from the Harriet Lane Handbook (23rd ed.) and Red Book 2021.
Indications & Pediatric Dosing
1. Community-Acquired Pneumonia (CAP) — ≥3 months
| Route | Dose |
|---|---|
| Oral (mild/step-down) | 10 mg/kg PO on Day 1 (max 500 mg), then 5 mg/kg/day PO Days 2–5 (max 250 mg/day) |
| IV then PO (severe) | 10 mg/kg/dose IV once daily × ≥2 days → 5 mg/kg/dose PO to complete 5-day course |
2. Pharyngitis / Tonsillitis (Group A Strep) — Ages 2–15 years
- 12 mg/kg/day PO once daily × 5 days (max 500 mg/day)
- Used when penicillin allergy is present
3. Acute Sinusitis — ≥6 months
- 10 mg/kg/dose PO once daily × 3 days (max 500 mg)
4. Pertussis (Whooping Cough)
| Age | Dose |
|---|---|
| 1–<6 months | 10 mg/kg/day PO once daily × 5 days |
| ≥6 months | 10 mg/kg PO on Day 1 (max 500 mg), then 5 mg/kg/day PO Days 2–5 (max 250 mg) |
Drug of choice for pertussis treatment and post-exposure prophylaxis in infants and children.
5. Mycobacterium avium Complex (MAC) in HIV-infected children
| Purpose | Dose |
|---|---|
| Primary prophylaxis | 20 mg/kg/dose PO once weekly (max 1200 mg); or 5 mg/kg/day PO (max 250 mg) |
| Secondary prophylaxis | 5 mg/kg/day PO (max 250 mg) + ethambutol ± rifabutin |
| Treatment | 10–12 mg/kg/day PO (max 500 mg/day) × ≥1 month + ethambutol ± rifabutin |
6. Endocarditis Prophylaxis
- 15 mg/kg/dose PO × 1 (max 500 mg), given 30–60 minutes before dental procedure
- Used in children with penicillin allergy
7. Cystic Fibrosis — Anti-inflammatory Use
| Weight | Dose |
|---|---|
| <18 kg | 10 mg/kg/dose PO every Mon/Wed/Fri |
| 18–<36 kg | 250 mg PO every Mon/Wed/Fri |
| ≥36 kg | 500 mg PO every Mon/Wed/Fri |
8. Bacterial Conjunctivitis (Ophthalmic — AzaSite 1%)
- ≥1 year: 1 drop in affected eye(s) BID (8–12 hr apart) × 2 days, then 1 drop once daily × 5 days
9. Other Indications (per Red Book 2021)
- Babesiosis — atovaquone + azithromycin combination
- Bartonella henselae (Cat-scratch disease)
- Chlamydia trachomatis infections
- Mycoplasma pneumoniae pneumonia
- Legionella pneumophila infections
- Lyme disease (alternative agent)
- Salmonella / Shigella infections
- Ureaplasma infections
- Genital ulcer disease / urethritis / cervicitis (adolescents)
Important Safety Points
- Not recommended for otitis media — increased resistant pathogens
- Contraindicated in macrolide hypersensitivity and prior cholestatic jaundice with azithromycin use
- Use caution with: hepatic impairment, GFR <10 mL/min, QT prolongation, hypokalemia, hypomagnesemia, bradycardia, arrhythmias
- Infantile hypertrophic pyloric stenosis has been reported — caution in neonates/young infants
- Cardiac risk: Can prolong QT interval — avoid in children on other QT-prolonging agents
- CNS penetration is poor
- Antacids (Al/Mg) reduce absorption — avoid concomitant use
- Macrolide resistance is a growing concern (>90% resistance in Mycoplasma in some Asian countries)
— The Harriet Lane Handbook, 23rd ed. (Johns Hopkins Hospital) | Red Book 2021, AAP Committee on Infectious Diseases
This is a shared conversation. Sign in to Orris to start your own chat.